Skip to main content

AtriCure, Inc. (ATRC) Stock Forecast 2025 - AI Price Prediction & Analysis


AtriCure, Inc. (ATRC) AI Stock Price Forecast & Investment Analysis

AtriCure, Inc. Stock Price Chart and Technical Analysis

Loading AtriCure, Inc. interactive price chart and technical analysis...

AtriCure, Inc. (ATRC) - Comprehensive Stock Analysis & Investment Research

Company Overview & Business Profile

AtriCure, Inc. (Stock Symbol: ATRC) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry. The organization employs approximately 1064 professionals worldwide . The company has established itself as an emerging investment opportunity with substantial growth potential.

Financial Performance & Key Metrics Analysis

Annual Revenue: $499 million generating a -75.1% net profit margin .

Market Capitalization: $1871 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 12.2% - Above-average shareholder return efficiency, indicating areas for operational improvement.

Advanced AI Stock Prediction & Price Target Analysis

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for AtriCure, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Market Position & Competitive Advantage Analysis

AtriCure, Inc. strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities . . The company maintains a healthy 646.2% gross margin, indicating strong pricing power and operational efficiency.

AtriCure, Inc. (ATRC) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for AtriCure, Inc. stock analysis.

Loading AtriCure, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into AtriCure, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if AtriCure, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For AtriCure, Inc.: With a P/E ratio of -39.61, the market sees the stock as potentially undervalued.

P/E Ratio -39.61x
P/B Ratio 4.03x
Market Cap $1871M
EPS $-0.77
Book Value/Share $9.35
Revenue/Share $10.06
FCF/Share $-0.88
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently AtriCure, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For AtriCure, Inc.: An ROE of 12.2% shows good shareholder value creation.

ROE 12.2%
ROA 8.1%
ROIC 11.2%
Gross Margin 646.2%
Operating Margin -65.9%
Net Margin -75.1%
EBT Margin 18.0%
Tax Rate 0.4%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess AtriCure, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For AtriCure, Inc.: A current ratio of 4.21 indicates strong liquidity.

Current Ratio 4.21x
Quick Ratio 3.21x
D/E Ratio 0.16x
Financial Leverage 1.26x
Interest Coverage 12.0x
Working Capital $258M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal AtriCure, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For AtriCure, Inc.: Free cash flow of $-41M indicates cash challenges that need attention.

Operating Cash Flow $-29M
Free Cash Flow $-41M
Capital Spending $-12M
FCF/Sales -14.1%
CapEx/Sales 4.1%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively AtriCure, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For AtriCure, Inc.: An asset turnover of 0.45x suggests room for improvement in asset utilization.

Asset Turnover 0.45x
Receivables Turnover 8.2x
Inventory Turnover 1.9x
Fixed Assets Turnover 8.7x
Days Sales Outstanding 44 days
Days Inventory 193 days
Payables Period 90 days
Cash Conversion Cycle 148 days
Understanding Financial Statement Data

What these metrics mean: Key figures from AtriCure, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For AtriCure, Inc.: With annual revenue of $499M, AtriCure, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $499M
R&D Expense $82M
SG&A Expense $73M
Cost of Goods Sold $108M
Balance Sheet Highlights ($ Millions)
Total Current Assets $34M
Cash & Short-term Investments $19M
Total Liabilities $21M
Short-term Debt $1M
Accounts Receivable $7M
Inventory $7M
Dividend & Shareholder Information
Shares Outstanding 50M
Growth Metrics (YoY)
EPS Growth -2.6%

Latest AtriCure, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting AtriCure, Inc. (ATRC) stock price and investment outlook.

, source: Yahoo Finance

AtriCure Reports First Quarter 2025 Financial Results MASON, Ohio, April 29, 2025--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation ...

, source: Business Wire

AtriCure, Inc. Valerie Storch-Willhaus, 612-605-3311 Media Relations Director, Corporate Marketing and Communications vstorch-willhaus@atricure.com or Andy Wade, 513-755-4564 Investor Relations ...

, source: Business Wire

Contacts AtriCure, Inc. Valerie Storch-Willhaus, 612-605-3311 Media Relations Director, Corporate Marketing and Communications vstorch-willhaus@atricure.com or Andy Wade, 513-755-4564 Investor ...

, source: The Motley Fool

So what: For the quarter, AtriCure delivered a 24.8% increase in revenue to $20.1 million -- $15.8 million of that coming from the U.S. -- as its adjusted loss per share narrowed to $0.13 from $0. ...

, source: Yahoo Finance

AtriCure to Host Analyst & Investor Day on March 26, 2025 MASON, Ohio, March 12, 2025--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation ...

AtriCure, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of AtriCure, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM Unlock Forecast $20M x 2.3x
AEMD Unlock Forecast $3M -0.1x 0.7x
AFIB Unlock Forecast $0M 0.0x -0.4x
ALUR Unlock Forecast $17M -0.4x -0.3x
AMIX Unlock Forecast $4M x 0.5x
ANGO Unlock Forecast $387M -1.4x 2.1x
ANIK Unlock Forecast $139M -4.3x 0.9x
AORT Unlock Forecast $1942M -198.2x 4.6x
APYX Unlock Forecast $81M -3.5x 11.2x
ARAY Unlock Forecast $138M -9.9x 2.8x
ATEC Unlock Forecast $2352M -7.4x 98.9x
ATRC Unlock Forecast $1871M -39.6x 4.0x
AVGR Unlock Forecast $2M -1.3x 0.4x
AVHHL Unlock Forecast $22M x x
BAX Unlock Forecast $12577M -94.9x 1.7x
BBNX Unlock Forecast $741M x 2.5x
BDX Unlock Forecast $56194M 35.5x 2.2x
BEAT Unlock Forecast $37M -5.7x 9.0x
BEATW Unlock Forecast $15M x 3.2x
BJDX Unlock Forecast $2M -0.5x 0.4x
BLAC Unlock Forecast $12M x -2.1x
BLACR Unlock Forecast $1M x -0.2x
BLACU Unlock Forecast $14M x -2.4x
BLACW Unlock Forecast $0M x 0.0x
BSX Unlock Forecast $156961M 62.6x 7.0x
BTCY Unlock Forecast $10M -2.7x -0.1x
BVS Unlock Forecast $647M -18.3x 4.0x
CERS Unlock Forecast $235M -13.8x 4.2x
CLPT Unlock Forecast $304M -23.5x 15.4x
CODX Unlock Forecast $12M -0.7x 0.3x
CTCX Unlock Forecast $5M -0.2x -1.2x
CTCXW Unlock Forecast $1M x -0.2x
CTSO Unlock Forecast $64M -1.8x 4.4x
CVRX Unlock Forecast $204M -5.5x 3.5x
DCTH Unlock Forecast $444M 198.7x 4.2x
DHAI Unlock Forecast $10M x -0.3x
DHAIW Unlock Forecast $1M x 0.0x
DRIO Unlock Forecast $30M 0.6x 0.4x
DRTS Unlock Forecast $269M x 3.1x
DXCM Unlock Forecast $30976M 54.2x 12.0x
EBRCZ Unlock Forecast $246M x 5.0x
EMBC Unlock Forecast $572M 15.8x -0.8x
FEMY Unlock Forecast $19M -1.4x 12.3x
FNA Unlock Forecast $1098M -15.4x 8.4x
FOFA Unlock Forecast $8M x 13.6x
GCTK Unlock Forecast $2M 0.9x -0.5x
GIPL Unlock Forecast $5M x 27.9x
GKOS Unlock Forecast $5241M -46.3x 6.9x
GMED Unlock Forecast $8479M 23.8x 2.0x
GUTS Unlock Forecast $88M x 13.8x
HAE Unlock Forecast $3541M 26.1x 4.3x
HRGN Unlock Forecast $26M x 34.6x
IART Unlock Forecast $1138M 200.2x 1.1x
ICAD Unlock Forecast $106M -3.1x 3.5x
ICCM Unlock Forecast $52M x 17.9x
ICU Unlock Forecast $8M -1.1x 13.3x
ICUCW Unlock Forecast $0M x -0.1x
ICUI Unlock Forecast $3248M -49.8x 1.6x
IDXG Unlock Forecast $24M 4.7x -0.9x
IINN Unlock Forecast $28M x 6.5x
IINNW Unlock Forecast $10M x 2.4x
INBS Unlock Forecast $10M -0.3x 3.4x
INFU Unlock Forecast $207M 40.8x 3.8x
INSP Unlock Forecast $2842M 53.5x 4.2x
IRMD Unlock Forecast $932M 45.1x 9.9x
IRTC Unlock Forecast $5319M -20.2x 51.3x
IVF Unlock Forecast $1M x 0.3x
KIDS Unlock Forecast $472M -20.7x 1.3x
KMTS Unlock Forecast $954M x x
KRMD Unlock Forecast $203M -19.8x 12.3x
LMAT Unlock Forecast $0M 58.7x 0.0x
LNSR Unlock Forecast $62M -6.7x -7.0x
LUCD Unlock Forecast $112M -0.6x 14.3x
LUNG Unlock Forecast $69M -4.3x 1.0x
LYRA Unlock Forecast $524M -0.1x 135.2x
MBOT Unlock Forecast $92M -1.3x 3.2x
MCAG Unlock Forecast $22M x -9.6x
MCAGU Unlock Forecast $21M x -9.9x
MDAI Unlock Forecast $69M -1.3x -42.3x
MDAIW Unlock Forecast $9M x -2.1x
MDNC Unlock Forecast $59M 26.8x 13.4x
MDXG Unlock Forecast $1093M 34.0x 5.1x
MGRM Unlock Forecast $196M -10.7x 22.7x
MHUA Unlock Forecast $13M x 0.1x
MMM Unlock Forecast $86020M 21.8x 20.1x
MMSI Unlock Forecast $5373M 45.1x 3.6x
MODD Unlock Forecast $38M -2.1x 2.2x
NARI Unlock Forecast $4677M -51.9x 10.8x
NAYA Unlock Forecast $2M -0.3x 0.2x
NEPH Unlock Forecast $39M -20.3x 2.0x
NMTC Unlock Forecast $39M -1.7x 4.8x
NPCE Unlock Forecast $297M -10.4x 15.3x
NSPR Unlock Forecast $120M -4.3x 5.9x
NURO Unlock Forecast $9M -0.5x 0.7x
NVAC Unlock Forecast $69M 84.3x -13.6x
NVACR Unlock Forecast $1M x -0.1x
NVACW Unlock Forecast $0M x 0.0x
NVCR Unlock Forecast $1390M -20.8x 4.0x
NVNO Unlock Forecast $87M -2.0x 2.3x
NVRO Unlock Forecast $221M -2.1x 1.0x
NXGL Unlock Forecast $20M -6.8x 4.2x
NXGLW Unlock Forecast $3M x 0.7x
OBIO Unlock Forecast $118M -3.4x 2.0x
OFIX Unlock Forecast $575M -5.8x 1.3x
OSRH Unlock Forecast $17M x 0.2x
OSUR Unlock Forecast $224M 17.1x 0.6x
PAVM Unlock Forecast $22M 0.3x 0.6x
PAVMZ Unlock Forecast $0M x 0.0x
PDEX Unlock Forecast $155M 16.5x 4.4x
PEN Unlock Forecast $10359M 70.1x 8.0x
PETV Unlock Forecast $18M -1.4x 12.0x
PLSE Unlock Forecast $1016M -2.6x 8.6x
PODD Unlock Forecast $23241M 98.4x 15.9x
PRCT Unlock Forecast $2188M -45.4x 5.7x
PROF Unlock Forecast $142M x 3.6x
PSTV Unlock Forecast $12M -0.3x -0.5x
PYPD Unlock Forecast $54M x 2.6x
RCEL Unlock Forecast $129M -5.0x -29.9x
RDGL Unlock Forecast $47M x 17.5x
RMD Unlock Forecast $42110M 30.1x 7.1x
RSMDF Unlock Forecast $2450M 1.8x 0.4x
RTGN Unlock Forecast $66M x x
RVP Unlock Forecast $25M -0.9x 0.3x
SGHT Unlock Forecast $220M -3.7x 3.1x
SIBN Unlock Forecast $705M -14.3x 4.1x
SINT Unlock Forecast $7M -0.5x 1.1x
SKIN Unlock Forecast $311M -1.8x 4.2x
SNOA Unlock Forecast $8M -5.6x 2.1x
SNWV Unlock Forecast $374M x -19.4x
SOLV Unlock Forecast $12731M 33.5x 3.5x
SRDX Unlock Forecast $432M -79.3x 3.9x
SRTS Unlock Forecast $51M 31.6x 1.0x
SSII Unlock Forecast $1535M x 37.9x
SSKN Unlock Forecast $7M -8.0x 23.7x
STIM Unlock Forecast $261M -1.0x 9.6x
STME Unlock Forecast $12M x x
STSS Unlock Forecast $8M -2.5x 0.5x
STSSW Unlock Forecast $0M x 0.0x
SYK Unlock Forecast $140684M 42.0x 12.0x
TCMD Unlock Forecast $313M 20.7x 1.6x
TELA Unlock Forecast $80M -1.8x 8.7x
TFX Unlock Forecast $5755M 30.0x 1.4x
TLSI Unlock Forecast $191M -3.6x -5.6x
TLSIW Unlock Forecast $66M x -1.9x
TMCI Unlock Forecast $628M -7.5x 6.0x
TNDM Unlock Forecast $806M -17.1x 6.0x
TNON Unlock Forecast $11M -0.3x 1.7x
TNONW Unlock Forecast $0M x 0.0x
TTOO Unlock Forecast $4M 0.0x -0.3x
UFPT Unlock Forecast $1757M 44.7x 4.9x
USAQ Unlock Forecast $2M x x
UTMD Unlock Forecast $200M 15.9x 1.7x
VERO Unlock Forecast $5M 0.0x 2.3x
VTAK Unlock Forecast $3M 0.0x 0.3x
VVOS Unlock Forecast $21M -0.5x 2.8x
WST Unlock Forecast $17997M 36.9x 6.1x
XAIR Unlock Forecast $303M -0.3x 22.3x
XTNT Unlock Forecast $95M -478.8x 2.0x

Frequently Asked Questions - AtriCure, Inc. Stock Forecast

How accurate are AtriCure, Inc. stock predictions?

Our AI model demonstrates 65% historical accuracy for ATRC predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence AtriCure, Inc. stock price forecasts?

Our analysis considers AtriCure, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is AtriCure, Inc. a good investment in 2025?

Based on our AI analysis, AtriCure, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are AtriCure, Inc. forecasts updated?

AtriCure, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced AtriCure, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for AtriCure, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...